Literature DB >> 11986007

Hypoosmotic stress stimulates growth in HepG2 cells via protein kinase B-dependent activation of activator protein-1.

R D Kim1, T P Roth, C E Darling, R Ricciardi, B K Schaffer, R S Chari.   

Abstract

Although hypoosmotic stress-induced cell swelling activates phosphatidylinositol-3-kinase, its impact on the downstream signal protein kinase B and cell growth is unknown. Activator protein-1 is in part phosphatidylinositol-3-kinase dependent, and is important in proliferation. We hypothesized that cell swelling modulates proliferation in HepG2 cells via the protein kinase B-dependent activation of activator protein-1. HepG2 cells pretreated with or without LY294002 were exposed for up to 30 minutes to hypoosmotic medium (160 mOsm/L). Tumor necrosis factor-alpha (1.4 nmol/L) or normoosmolar medium (270 mOsm/L) served as positive and negative controls, respectively. Western immunoblots measured cytoplasmic phosphorylated and total protein kinase B. Electromobility shift assays measured nuclear activator protein-1. Methylene blue assays measured cell proliferation at 24, 48, and 72 hours after stimulation. Hypoosmotic stress phosphorylated protein kinase B by 10 minutes. Subsequently, hypoosmotic exposure stimulated activator protein-1 by 30 minutes. Pulse exposure to hypoosmotic stress potentiated HepG2 proliferation by 72 hours as compared to both negative controls and LY-inhibited cells (n = 4 per group, P = 0.009 and P = 0.004, respectively; P <0.001 analysis of variance. All three activation events were abolished with LY294002 pretreatment. In HepG2 cells, hypoosmotic stress-induced swelling stimulates proliferation via protein kinase B-mediated activation of activator protein-1. These data delineate a possible mechanism linking changes in cell volume to growth in human liver cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11986007     DOI: 10.1016/s1091-255x(01)80094-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  34 in total

1.  Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice.

Authors:  M Yoshida; K Miyajima; K Shiraki; J Ando; K Kudoh; D Nakae; M Takahashi; A Maekawa
Journal:  Cancer Lett       Date:  1999-07-01       Impact factor: 8.679

2.  Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation.

Authors:  T R Walker; S M Moore; M F Lawson; R A Panettieri; E R Chilvers
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

3.  Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration.

Authors:  C Duan; J R Bauchat; T Hsieh
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

4.  Signal transduction during liver regeneration.

Authors:  D A Brenner
Journal:  J Gastroenterol Hepatol       Date:  1998-09       Impact factor: 4.029

5.  The role of disulfide-linked dimerization in interleukin-3 receptor signaling and biological activity.

Authors:  F Le; F Stomski; J M Woodcock; A F Lopez; T J Gonda
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

6.  Mitochondrial permeability transition is altered in early stages of carcinogenesis of 2-acetylaminofluorene.

Authors:  P C Klöhn; A Bitsch; H G Neumann
Journal:  Carcinogenesis       Date:  1998-07       Impact factor: 4.944

7.  Effects of calcium channel blockers on NIH 3T3 fibroblasts expressing the Ha-ras oncogene.

Authors:  P C Dartsch; M Ritter; M Gschwentner; H J Lang; F Lang
Journal:  Eur J Cell Biol       Date:  1995-08       Impact factor: 4.492

8.  Administration of Escherichia coli endotoxin to rat increases liver mass and hepatocyte volume in vivo.

Authors:  D Qian; J T Brosnan
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

9.  In vitro stimulation of human fetal lymphocytes by mitogens and interleukins.

Authors:  U Settmacher; H D Volk; R von Baehr; H Wolff; S Jahn
Journal:  Immunol Lett       Date:  1993-02       Impact factor: 3.685

10.  Activation of Jun kinase is an early event in hepatic regeneration.

Authors:  J K Westwick; C Weitzel; H L Leffert; D A Brenner
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.